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Monokines have been increasingly recognized as communication signals that 
interact with both immune and non-immune cells during inflammation. Specifically, 
interleukin-lalpha (IL-lalpha), interleukin-lbeta (IL-lbeta) and tumor necrosis factor- 
alpha (TNF-alpha) possess potent effector activities on various cell types. We present 
novel data demonstrating that human endothelial ceils are a major source of a 
neutrophil chemotactic factor (NCF) synthesized upon stimulation with either IL- 
lalpha, IL-lbeta, or TNF-alpha; but not with interleukin-6 (IL-6). Northern blot 
analysis demonstrated that 20 ng/ml of either IL-1 or TNF-alpha could induce 
endothelial ceils to express significant levels of NCF mRNA, while IL-6 was not active 
in this system. These data demonstrate that monokines play an important role in 
mediating acute inflammation via induction of an endothelial cell-derived NCF. 
© 1988 Academic Press, Inc. 
The evolution of an inflammatory response is dependent upon cell-to-cell 
communication via protein signals that bind to specific receptors and result in target 
cell activation. These complex events are mediated by products of both immune ceils 
found in tissue and the peripheral circulation, as well as endothelial ceils that line the 
vasculature. A number of studies have demonstrated that endothelial cells are 
susceptible to cytokine-induced stimulation that results in altering endothelial cell 
function leading to the active participation of this cell in inflammation (1-5). 
Specifically, both IL-1 and TNF-alpha can induce adherence proteins on the surface of 
endothelial cells that bind polymorphonuclear leukocytes (6-7). The expression of 
these surface proteins are potentially an important mechanism for trapping circulating 
Abbreviations used in this manuscript: IL-1, interleukin-1, TNF, tumor necrosis factor 
alpha; IL-6, interleukin-6, NCF, neutrophil chemotactic factor. 
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neutrophils in a localized area of tissue injury, yet this process does not account for the 
selective influx of neutrophils into an area of local inflammation. 
In this paper, we present novel data demonstrating that monokine-activated 
endothelial cells may further contribute to acute inflammation by the production of a 
specific neutrophil chemotactic factor (NCF). Either IL-1 alpha, IL-1 beta, or TNF- 
alpha-treated endothelial cells induced a time- and dose-dependent increase in NCF 
mRNA expression and the production of chemotactic activity. The induction of NCF 
mRNA and the secretion of biologically-active protein possessed a degree of cytokine 
selectivity, as interleukin-6-treated human endothelial cells was not effective in this 
system. These studies demonstrate that either IL-1 or TNF can induce NCF gene 
expression by endothelial cells and this factor may play a major role in the early influx 
of neutrophils from the circulation. 
Materials  and Methods 
Endothelial Cell Populations: Human endothelial cells were isolated from umbilical 
veins according to previously published procedures (8). The recovered endothelial cells 
were cultured in medium 199 supplemented with 100 ng/ml endothelial cell growth 
supplement, 25% fetal bovine serum, and 100 ng/ml bovine lung heparin. All cells in 
these studies were used prior to their fifth passage in culture. Twenty-four hours before 
stimulation, the endothelial cells were washed and new media, minus growth factors, 
were added. 
Reagents: Human recombinant IL-lalpha and IL-lbeta with specific activities of 20 
U/ng and 30 U/ng, respectively, were the generous gifts of the Upjohn Company. 
Human recombinant TNF (20 U/ng, specific activity) was a gift of the Cetus 
Corporation. Human recombinant IL-6 (20 U/ul) was purchased from Genzyme Inc. 
Northern Blot Analysis: Total endothelial cell RNA was extracted using a 
modification of the methods of Jonas et al. (9). and Chirgwin et al. (10). The adherent 
endothelial cells were solubilized in a solution of 25 mM Tris, pH 8.0 containing 4.2 M 
guanidine isothiocyanate, 0.5% Sarkosyl and 0.1 M beta-mercaptoethanol. After 
homogenization, an equal volume of 100 mM Tris, pH 8.0 containing 1.0% SDS and 10 
mM EDTA was added and the RNA extracted with chloroform-phenol. The alcohol 
precipitated RNA was separated by formaldehyde/l% agarose gels and transblqt//ed to 
nitrocellulose. The baked blots were prehybridized and then hybridized with a J~P -5'- 
end labeled 30 mer oligonucleotide probe. The probe was complementary to 
nucleotides 262-291 of a published cDNA sequence for human monocyte-derived NCF 
(11). The sequence of the probe was 5'-GTT-GGC-GCA-GTG-TGG-TCC-ACT-CTC- 
ATI~-CAC-3 '. Blots were stringency washed and autoradiographs were quantitated by 
laser densitometry. Equivalent amounts of total RNA load per gel lane were assessed 
by monitoring 28 and 18S rRNA. 
Neutrophil Chemotact ic  Factor Assay: Human neutrophils were prepared from 
peripheral blood by Ficoll-Hypaque density gradient centrifugation, followed by 
sedimentation in 5% Dextran/0.9% saline (Sigma Chemical Co., St. Louis, MO). 
Neutrophils were isolated from erythrocytes by hypotonic lysis then resuspended in 
Hanks balanced~salt solution (HBSS) with calcium/magnesium (Gibco, Grand Island, 
NY) at 2 x 10 u cells/ml with greater than 95% viability by trypan blue exclusion. 
Chemotaxis was performed using Oe method of Harvath et al (12). Briefly, 20 ul of 
diluted supernatant specimen, 10 -I M formyl methionylleucylphenylalanine (FMLP, 
Sigma Chemical Co., St. Louis, MO) or HBSS alone were placed in duplicate bottom 
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wells or a 48-well microchemotaxis chamber (Neuro probe, Cabin John, MD). A 3 
micron pore-size polycarbonate filter (polyvinylpyrolidone-free, Nucleopore Corp.) was 
placed in the assembly and 50 ul of neutrophil suspension placed in each of the top 
wells. After incubating at 37°C in humidified 95% air/5% ~ O ~  for 0.5 hrs, the filters 
were removed, fixed in methanol, and stained with Diff-Quil~ (American Scientific 
Products, McGaw Park, IL). Neutrophils that had migrated through to the bot tom of 
the filter were counted in 10 high power fields. Chemotactic activity was assessed as 
percent of the FMLP positive control. 
Results 
Monokine-lnduced Expression of NCF mRNA: Initially, human endothelial cells 
grown to confluency were stimulated for 16 hours with 200 Units/ml of either IL-1 
alpha, IL-1 beta, TNF-alpha or IL-6 and total RNA was recovered. Northern blot 
analysis demonstrated a significant expression of NCF m R N A  from either IL-1 alpha, 
IL-1 beta, or TNF-alpha-treated endothelial cells (Figure 1). On the contrary, IL-6- 
stimulated endothelial cells did not induce NCF mRNA expression. The insert in 
Figure 1 shows the Northern blot (top) and the corresponding 28 and 18S ribosomal 
RNA (bottom). Characterization of the Northern blot demonstrated an NCF mRNA 
species of 1.8 Kb. The cells that had media alone demonstrated only a trace of NCF 
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Figure 1. Induction of endothelial cell derived NCF mRNA by IL-1 and TNF- 
alpha, but not IL-6. Human endothelial cells were treated with 200 Units/ml of 
each cytokine and total RNA was extracted 16 hours post-challenge. The insert 
shows the Northern blot (top) of the NCF mRNA compared to the 28 and 18S 
ribosomal RNA (bottom). The bar graph represents the laser densitometry of 
the individual autoradiographs. 
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m R N A  during the study period. As shown by the laser densitometry data in Figure 1, 
IL-1 beta and TNF-alpha stimulated endothelial cells possessed nearly equal potency in 
inducing the expression of NCF mRNA, while IL-1 alpha appeared less effective. 
Production of  Biologically-Active NCF by IL-1 and TNF-Treated Endothelial Cells: In 
order to correlate the production of chemotactic activity with the expression of NCF 
mRNA, supernatant I¥om control, IL-1 alpha, IL-1 beta, or IL-6-treated endothelial 
cells were assessed for the production of chemotactic activity. As shown in Figure 2, 
IL-1 alpha, IL-1 beta, and TNF-alpha-induced the synthesis of significant levels of NCF 
activity by 16 hours, while the level of IL-6-induced NCF was identical to the media 
control. An approximate 12-fold increase above controls in the levels of biologically- 
active NCF was observed when endothelial cells were challenged with 20 ng/ml of 
either of the stimulating monokines. 
Kinetic Analysis of  Monokine-Induced NCF Bioactivity: In order to assess the time- 
dependent increase in the production of NCF, endothelial cells were treated with 20 
ng/ml of either IL-1 alpha or IL-1 beta and chemotactic activity determined 2, 4, 8, and 
24 hours later. As shown in Figure 3, either IL- la lpha or IL-lbeta-induced the 
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Figure 2. Production of neutrophil chemotactic activity by either IL-1 alpha, IL-1 
beta, or TNF-alpha treated human endothelial cells. The endothelial cells were 
exposed to each cytokine (200 Units/ml) for 16 hours and the supernatant was 
assessed for neutrophil chemotactic activity. Both IL-1 and TNF-alpha 
effectively induced the synthesis of de novo  chemotactic activity, while IL-6 was 
ineffective in this system. 
Figure3. Time-dependent production of neutrophil chemotactic activity by 
monokine treated endothelial cells. Both IL-1 alpha and IL-1 beta (200 
Units/ml) treated endothelial cells demonstrated a time-dependent increase in 
the production of NCF. Although the secretion of endothelial cell NCF was 
initially low (0-4 hours), the production significantly increased at the 8 and 24 
hour time points. TNF-alpha treated human endothelial cells exhibited a similar 
kinetic pattern of NCF expression. 
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NCF could be assessed. At 8 hours post-IL-1 challenge, the endothelial cell 
supernatant contained a 4-5 told increase in NCF activity above controls. Twenty-four 
hours alter IL-1 stimulation, the endothelial cell-derived NCF activity was 
approximately 8-fold above controls. Endothelial cells treated with IL-6 did not 
increase the levels of NCF above control values, while TNF-alpha treatment 
demonstrated activity consistent with the IL-1 treated endothelial cells (data not 
shown). 
Discussion 
It is becoming increasingly apparent that endothelial cells are important 
participants in the initiation and maintenance of acute inflammation. The anatomical 
location of these cells places the endothelium in a pivotal position to provide a 
communication bridge between the inflammatory cells of the peripheral blood and the 
interstitium. Previous studies have demonstrated that endothelial cells are susceptible 
to stimulation/activation by cytokines derived from either T-cells (6) or macrophages 
(1,4). In the latter case, IL-1 and TNF have been identified as specific macrophage- 
derived proteins that possess overlapping effector activities on endothelial cells. Both 
IL-1 and TNF can induce the production of endothelial cell-derived tissue factor (5,13), 
arachidonate metabolites (14), platelet-derived growth factor (15) and neutrophil 
adherence proteins (6,7). 
In addition to influencing neutrophil function via the induction of specific 
adherence proteins, we now demonstrate that either IL-lalpha, IL-lbeta, or TNF can 
stimulate endothelial cells to produce a potent neutrophil chemotatic factor. Thus, 
monokine/endothelial cell interactions cannot only induced the adherence of 
neutrophils in a defined area of inflammation, but also initiate the unidirectional 
movement of these cells into an inflamed area in a polarized fashion. Interestingly, the 
induction of cytokine-induced NCF production by endothelial cells demonstrated 
selectivity, as IL-6 was not effective in this system. In total, these studies show that 
monokines can stimulate the production of a neutrophil chemotactic factor from 
human endothelial ceils that may have important consequences in acute, neutrophil- 
mediated inflammation. 
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